IQVIA Holdings Inc. (NYSE:IQV) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of IQVIA Holdings Inc. (NYSE:IQV - Get Free Report) have received an average recommendation of "Moderate Buy" from the twenty-four analysts that are presently covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $226.32.

Several equities research analysts have weighed in on the company. Truist Financial cut their target price on IQVIA from $263.00 to $216.00 and set a "buy" rating for the company in a research note on Thursday, April 10th. HSBC cut IQVIA from a "buy" rating to a "hold" rating and cut their target price for the stock from $260.00 to $160.00 in a research note on Friday, April 25th. Hsbc Global Res cut IQVIA from a "strong-buy" rating to a "hold" rating in a research note on Friday, April 25th. Wall Street Zen cut IQVIA from a "buy" rating to a "hold" rating in a research note on Wednesday, March 12th. Finally, Citigroup restated a "neutral" rating on shares of IQVIA in a research note on Thursday, May 22nd.

IQVIA Trading Up 2.2%

Shares of IQV stock opened at $158.63 on Wednesday. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 2.19. The stock has a market cap of $27.44 billion, a P/E ratio of 21.61, a price-to-earnings-growth ratio of 1.70 and a beta of 1.28. The stock has a 50 day simple moving average of $148.49 and a 200 day simple moving average of $175.30. IQVIA has a 1 year low of $134.65 and a 1 year high of $252.88.

IQVIA (NYSE:IQV - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The medical research company reported $2.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.07. The business had revenue of $3.83 billion during the quarter, compared to analysts' expectations of $3.77 billion. IQVIA had a return on equity of 29.16% and a net margin of 8.61%. The firm's revenue for the quarter was up 2.5% compared to the same quarter last year. During the same period in the previous year, the company posted $2.54 earnings per share. On average, research analysts predict that IQVIA will post 10.84 earnings per share for the current fiscal year.

Institutional Trading of IQVIA

A number of institutional investors and hedge funds have recently bought and sold shares of IQV. American National Bank & Trust acquired a new stake in IQVIA in the first quarter valued at $26,000. Clal Insurance Enterprises Holdings Ltd boosted its position in IQVIA by 436.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 161 shares of the medical research company's stock valued at $28,000 after acquiring an additional 131 shares during the last quarter. Golden State Wealth Management LLC boosted its position in IQVIA by 295.5% during the first quarter. Golden State Wealth Management LLC now owns 174 shares of the medical research company's stock valued at $31,000 after acquiring an additional 130 shares during the last quarter. AllSquare Wealth Management LLC bought a new stake in IQVIA during the first quarter valued at $33,000. Finally, ST Germain D J Co. Inc. boosted its position in IQVIA by 66.1% during the first quarter. ST Germain D J Co. Inc. now owns 191 shares of the medical research company's stock valued at $34,000 after acquiring an additional 76 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.